A
Anushka Patel
Researcher at The George Institute for Global Health
Publications - 337
Citations - 29250
Anushka Patel is an academic researcher from The George Institute for Global Health. The author has contributed to research in topics: Diabetes mellitus & Type 2 diabetes. The author has an hindex of 69, co-authored 315 publications receiving 25272 citations. Previous affiliations of Anushka Patel include Northwestern University & Ministry of Health (New South Wales).
Papers
More filters
Journal ArticleDOI
Impact of switching to polypill based therapy by baseline potency of medication: Post-hoc analysis of the SPACE Collaboration dataset.
Ruth Webster,Chris Bullen,Anushka Patel,Vanessa Selak,Sandrine Stepien,Simon Thom,Anthony Rodgers +6 more
TL;DR: The adherence benefits of polypills tend to offset the loss of potency from use of individual components with lower dose potency, and to facilitate improvements in multiple risk factors.
Journal ArticleDOI
The Post Hoc Use of Randomised Controlled Trials to Explore Drug Associated Cancer Outcomes: Methodological Challenges
Gudrun Stefansdottir,Gudrun Stefansdottir,Sophia Zoungas,Sophia Zoungas,John Chalmers,Miriam J. Knol,Miriam J. Knol,Hubert G. M. Leufkens,Mark Woodward,Anushka Patel,Diederick E. Grobbee,Marie L. De Bruin +11 more
TL;DR: Challenges of exploring drug-associated cancer outcomes by post-hoc analyses of Randomised controlled trials (RCTs) designed for other purposes are discussed.
Journal ArticleDOI
I-CARE randomized clinical trial integrating depression and acute coronary syndrome care in low-resource hospitals in China: Design and rationale.
Shenshen Li,James A. Blumenthal,Chuan Shi,Danielle Millican,Xian Li,Xin Du,Anushka Patel,Pei Gao,Elizabeth R. DeLong,Pallab K. Maulik,Runlin Gao,Xin Yu,Yangfeng Wu,Yangfeng Wu +13 more
TL;DR: The I-CARE trial will be the largest study to test the effectiveness of an integrated care model on depression and cardiovascular outcomes among ACS patients in resource-limited clinical settings.
Journal ArticleDOI
Heart Failure Therapies for the Prevention of HER2-Monoclonal Antibody-Mediated Cardiotoxicity: A Systematic Review and Meta-Analysis of Randomized Trials.
Lauren J. Brown,Thomas Meredith,Jie Yu,Anushka Patel,Anushka Patel,Anushka Patel,Bruce Neal,Bruce Neal,Bruce Neal,Clare Arnott,Clare Arnott,Clare Arnott,Elgene Lim,Elgene Lim,Elgene Lim +14 more
TL;DR: This article performed a systematic review and meta-analysis of randomized controlled trials to evaluate pharmacotherapy for the prevention of monoclonal HER2-directed antibody-induced cardiotoxicity in patients with breast cancer.
Journal ArticleDOI
Association of Low-Dose Triple Combination Therapy vs Usual Care With Time at Target Blood Pressure: A Secondary Analysis of the TRIUMPH Randomized Clinical Trial.
Sonali R. Gnanenthiran,Nelson Wang,Gian Luca Di Tanna,Abdul Salam,Ruth Webster,H Asita de Silva,Rama K Guggilla,Stephen Jan,Pallab K. Maulik,Nitish Naik,Vanessa Selak,Simon A. McG. Thom,Dorairaj Prabhakaran,Aletta E. Schutte,Anushka Patel,Anthony Rodgers +15 more
TL;DR: This analysis provides the first estimate of time at target as an outcome assessing longitudinal BP control in a randomized clinical trial, and among patients with mild to moderate hypertension, treatment with a low-dose triple combination pill was associated with substantially higher time attarget compared with usual care.